Geneva, Switzerland and Boston, MA – May 3, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization…
Month: May 2019
ObsEva SA to Hold First Quarter 2019 Financial Results and Business Update Call on May 9, 2019
Geneva, Switzerland and Boston, MA –May 1, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and…